Block copolymeric biotransport carriers as versatile vehicles for drug delivery

Expert Opinion on Biological Therapy

Volumn 1, Issue 4, 2001, Pages 583-602

  Alakhov, Valery ^a   Klinski, Evgueni ^a   Lemieux, Pierre ^b   Pietrzynski, Grzegorz ^b   Kabanov, Alexander ^b  

^a Supratek Pharma Inc   (Canada)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Biological response modifying agent; Block copolymers; Combinatorial chemistry; Drug delivery; Micelles

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL RESPONSE MODIFIER; DRUG CARRIER; EXCIPIENT; POLYMER;

ANIMAL; CELL LINE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG EFFECT; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; MICELLE; MULTIDRUG RESISTANCE; REVIEW; TRANSPORT AT THE CELLULAR LEVEL;

ANIMAL; ANTINEOPLASTIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; BIOLOGICAL TRANSPORT; CELL LINE; CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; EXCIPIENTS; GENE EXPRESSION REGULATION; HUMAN; MICELLES; MOLECULAR STRUCTURE; POLYMERS;

EID: 0035407446     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.1.4.583     Document Type: Article

References (130)

1. ALAKHOV VY, KABANOV AV: Block copolymeric biotransport carriers as versatile vehicles for drug delivery. Expert Of in. Investlg. Drugs (1998) 7(9):1453-1474.
2. KABANOV AV, NAZAROVAIR, ASTAFIEVAIV aal: Micelle formation and solubilization of fluorescent probes in poly(oxyediylene-b-oxypropylene-boxyethylene) solutions. Macromoltcules (1995) 28:2303-2321.
3. NAGARAJAN R, GANESH K: Synthesis and antibacterial evaluation of N-alkyl vancomycins. Macromoltcules (1989) 22:4312-4321.
4. SCHMOLKAIR: Physical basis for poloxamer interactions. J.Am. OilChcm. Soc. (1977)54:110-126.
5. LINSE P: Micellization of polyethylene oxide) polypropylene oxide) block copolymers in aqueous solutions. Macromoltcults (1993) 26:4437-4449.
6. HUNGER PN, SCHELTENS JMHM, DAYTON TA: Molecular modelling of micelle formations and solibilization in block copolymer micelle. Macromolfculcs (1993) 26:5030-5052.
7. ASTASEVALZHONGXEESENBERGA: Critical micellization phenomena in block polyelectrolites. Macromolcailes (1993) 26:7339-7342.
8. MAIMSTEN M, LINDMAN B: Selfassembly in aqueous block copolymer solutions. Macromoltcules (1992) 25:54405456.
9. GROOT RD, WARREN PB: Dissipative particle dynamics: bringing the gap between atomistic and mesoscopic simulation. J. Chftn. Phys. (1997) 107:4423-4435.
10. BASF Performance Chemicals. BASF Co., Parsipany.NJ, USA (1991).
11. YAMAMOTOY.NAGASAKYY.KATOM, KATAOKA K: Colloidal stability and drug incorporation aspects of micellar-like PLA-
12. PEG nanoparticles. Colloids and Surfaces B: Biomterfaces (1991) 16:135-147.
13. ZHANG X, JACKSON JK, BURT HM: Preparation and characterization of the micelle-forming polymeric drugs. Int. J. PhantiacoL (1996) 85:85-98.
14. YOKOYAMAM,KWONGS,OKANOT, SAKURAIY, NAITO M, KATAOKA K: Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. CanarRcs. (1990) 50:1693-1700.
15. KWONG, NAITO M.YOKAYAMAM, OKANO T, SAKURAI Y, KATAOKA K: Enhanced tumor accumulation and prolonged circulation times of micelleforming polyethylene oxide-aspartate) block copolymer-adriamycin conjugates. J. Contr. Release (1997) 48:195-202.
16. LA SB, OKANO T, KATAOKA K: Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorpo rated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles.J. Pharm. Sei. (1996) 85:85-90.
17. KIM SW, SHIN IG, LEE YM, CHO CS,
18. SUNG YK: Block copolymer micelles as vehicles for drug delivery. J. Contr. Release (1998) 51:13-18.
19. ALLEN C.MAYSINGERD, EISENBERG A; Polycaprolactone-b-poly(ethylcne oxide) block copolymer micelles as a novel drug delivery vehicle for neurotrophic agents FK506 and L-685,818. Bioconj. Chem. (1998) 9:564-572.
20. JEONG YI, CHEON JB, KIM SH: Clonazepam release from poly(DL-lactideco-glycolide) nanoparticles prepared by dialysis method. Arch. Pharm. Res. (1998) 4:418-422.
21. RAMASWAMYM,ZHANGX,BURT HM, WASAN KM: Human plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers./ Pharm. Sei. (1997) 86:460-464.
22. KATAYOSE S, KATAOKA K: Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with polyethylene glycol)-poIy(L-lysine) block copolymer./ Pharm. Sei. (1998) 87:160-164.
23. NGUYENHN.LEMIEUXP, VINOGRADOVS etal: Evaluadon of polyether-polyediyleneimine graft copolymers as gene transfer agents. Gene Ther. (2000)7:126-138.
24. ENDERBYCJM.LEYTEJGThe distribution of water around poly(ethyleneoxide): a neutron diffraction study.J. Phys. Chem. (1994) 98:6568-6578.
25. UNTER RJ: Foundations of Colloid Science. Oxford University Press, New York, USA (1991) 1:38.
26. KWON GS, OKANO T: Synthetic studies of vitamin D analogs. XXII. Synthesis and antiproliferation activity of putative metabolites of 1 alpha, 25-dihydroxy-22oxavitamin D3. advan. Drug Delivery Rev. (1996)21:107-116.
27. KABANOVAV,ALAKHOVVY:New approaches to targeting of bioactive compounds./ Contr. Release (1994) 28:1522.
28. KABANOV AV, NAZAROVAIR, ASTAFIEVAIV: Micelle formation and solubilisation of fluorescent probes in poly(oxyethylene-b-oxypropylene-boxyethylene) solutions. Macromolecules (1995)28:2303-2311.
29. EISENBERG A: Thermod)-namic vs. kinetic aspects in the formation and morphological transitions of crew-cut aggregates produced by self-assembly of polystyrene-b-poly(acrylic acid) block copolymers in dilute solution. Macromolfcults (1999) 32:2239-2249.
30. ALEXANDRIDIS P, HATTON TA: Colloids Surf. A Phisicochem. Eng. Asp. (1995) 96:1.
31. NAGARAJAN R: Comparison of solubilization of hydrocarbons in (PEOPPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles. Curr. Of in. ColloidInterf. Sei. (1996) 1:391-398.
32. ZHANG L, EISENBERG A: Compliance measurements of confined polystyrene solutions by atomic force microscopy. Science (1995) 268:1728-1732.
33. ZHANG L.YUK, EISENBERG A: Ioninduced morphological changes in 'crewcut aggregates of amphiphilic block copolymers. Science (199'6) 272:1777-1782.
34. ZHANG L, BARLOW, EISENBERG A: Wetting behavior of homopolymer films on chemically similar block copolymer surfaces. MacromoUcules (1995) 28:60556063.
35. DESJARDINS A, EISENBERG A: Aggregation and critical micelle concentrations of polystyrene-bpoly(sodium acrylate) and polysryrene-bpo!y(acrylic acid) micelles in organic media. Macnmolecuks (1991) 24:5779-5784.
36. JOHNSON DL, POLIKANDRITOULAMBROS M, MARTONEN TB: Theoretical relationship of lung deposition to the fine particle fraction of inhalation aerosols.J. DrugDeliv. Targ. Therapeutic Agents (1996) 3:9-16.
37. BRONICH TK, SOLOMATIN SV, YAROSLAVOV AA, EISENBERG A, KABANOV VA, KABANOVAV: Steric stabilization of negatively charged liposomes by canonic graft copolymer. Langmuir (2000)11:4877-4881.
38. GAOZ, EISENBERG A: A model of micellization for block copolymer in solutions. MacromoUcules (1993) 26:73537362.
39. SCHLILLEN K, BROWN W, JOHNSON RM: Micellar sphere-to rod transition in an aqueous triblock copolymer system. A dynamic light scattering study of translations! and rotational diffusion. Macromoleculti (1994) 27:4825-4833.
40. WILHELM M.ZHAOC-L, WANG Y et al: Poly(sterene-ethylene oxide). Block copolymer micelle formation in water: a fluorescence probe study. Macromolecules (1991) 28:2303-2312.
41. NAGARAJAN R: Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-POP-PEO) block copolymers. Colloids Surf. (1999) 16:55-72.
42. NAGARAJAN R, WANG CG Theory of surfactant aggregation in water/ethylene glycol mixed solvents. Langmuir (2000) 12:5242-5251.
43. NAGARAJAN R, GANESH K: Comparison of solubilization of hydrocarbons in (PEO-PPO) diblock versus (PEO-PPO-PEO) triblock copolymer micelles. Macromolecules (1989) 22:489499.
44. NAGARAJAN R, GANESH K: Solubilization of hydrocarbons in (PEOPPO) diblock versus (PEO-PPO-PEO) triblock copolymers.J. ColloidInterf Sei. (1996) 184:489-496.
45. SOKOL RJ, JOHNSON KE, KARRER FM, NARKEWICZ MR, SMITH D, KAM I: Improvement of cyclosporin absorption ~ in children after liver transplantation by means of water-soluble vitamin E. Lancet (1991)338:212-214.
46. HANDE KR, KROZELY MG, GRECO FA, HAINSWORTH JD, JOHNSON DH: Bioavailability of low-dose oral etoposide./ Clin. OncoL (1993) 2:374-377.
47. MYERS JS, KEARNEY K: Emergency. Chemotherapy-induced hypersensitivity reaction. Am.]. Nun. (2000) 4:53-54.
48. KWON GS, KATAOKA K: Block copolymer micelles as long-circulating drug vehicles. yLAi Drug. Delivery Rev. (1995) 16:295-301.
49. YOKOYAMA M, SUGIYAMA T, OKANO T étal: Analysis of micelle formation of an adriamycin-conjugated polyethylene glycol)-poly(aspartic acid) block copolymer by gel permeation chromatography. Pharm. Res. (1993) 10:895-901.
50. KWON GS.NAITOM, YOKOYAMA M et ai: Physical entrapment of adriamycin in AB block copolymer micelles. Pharm. Res. (1995) 12:192-198.
51. RAPOPORT N: Stabilization and activation of Pluronic micelles for tumor-targeted drug deliver)'. Colloids Surf. (1999) 16:93-112.
52. KWON GS, KATAOKA K: Block copolymer micelles as long-circulating drug vehicles. Adv. Drug. Delivery Rtv. (1995) 16:295-299.
53. BURTHM,ZHANGX,TOLIEKISP, EMBREE L, HUNTER W: Development of copolymers of poly(D,L-Iactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf. (1999) 16:161-172.
54. WATSON JC, SUTANTO-WARD E, OSAKU M, WEINSTEIN JK, BABB JS, SIGURDSON ER: Importance of timing and length of administration of angiogenesis inhibitor TNP-470 in the treatment of K12/TRb colorectal hepatic métastases in BD-DC rats. Surgery A999) 126:358-363.
55. ALAKHOVV.KLINSKIE.LIS: Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials. Colloids Surf. (W1)) 16:113-134.
56. LIU M, VLADIMIROV N, FRÉCHETV JMJ: A new approach to hypcrbranched polymers by ring-opening polymerization of an AB monomer: 4-(2-hydroxyethyl)caprolactone. Macromolecules (1999) 32:6881-6884.
57. SMITH DK.DIEDERICHF: Comparison of the capacity of beta-cyclodextrin derivatives and cyclophanes to shutde cholesterol between cells and serum lipoproteins. Chem. Eur.J. (1998) 4:13531363.
58. GRUBBS RB, HAWKER CJ, DAO J, FRECHET JMJ: The melt viscosity of dendritic poly(benzyl ether) macromolecules. Int. Ed. EngL (1997) 36:270-281.
59. GAUTHIERM.TICHAGWAL, DOWNEY JS, CAO S: Arborescent graft copolymers: highly branched macromolecules with a core-shell morphology. Macromolecules (1996) 29:519-527.
60. TANAKA T: Viscoelastic properties of miscible poly(methyl methacrylate)/ poly(styrene-co-acrylonitrile) blends in die molten state. Macromolecules (1999) 32:8560-8565.
61. TAKASHI I, KINTSU K, YAMAMOTO H: NMR study of the solution structures of the inclusion complexes of -cyclodextrin with (-0-catechin and (-)-epicatechin.J. Phys. Chem. (1999) 103:8992-8997.
62. TPANEKM.PROCHAZKAK: Fluorometric studies of the polyelectrolyte shell of block copolymer micelles in aqueous media. Zag7n;> (1999) 15:8800-8806.
63. ZHANG Q, TSUIOKC, DU B, ZHANG F, TANG T, HE T: Observation of inverted phases in poly(styrene-b-butadiene-bstyrene) triblock copolymer by solventinduced order-disorder phase transition. Afafromolecul(s(20QO) 33:9561-9567.
64. WOOLEY KL: Location of fluorotryptophan sequestered in an amphiphilic nanoparticle by rotational-echo double-resonance NMR. Chem. EUT. ]. (1997) 3:1397-1399.
65. THURMOND KB, HUANG H, CLARK CG, KOWALEWSKIT, WOOLEY KL: Solubilization of hydrocarbons and resulting aggregate shape transitions in aqueous solutions of Pluronic (PEO-PPOPEO) block copolymers. Colloids Surf. (1999) 16:45-54.
66. MORTENSEN K, PERDERSEN S: Shearinduced transition of originally undisturbed lamellar phase to vesicle phase. Mocromoltclules (1993) 26:805-811.
67. JHONSTONTP, PUNJABI MA, FROELICH CJ: Sustained delivery of interIeukin-2 from a poloxamer 407 gel matrix following intraperitoneal injection in mice. Pharm. Rts. (1992) 9:425-431.
68. CAMMASS, SUZUKI K, SOME Y, SAKURAIY, KATAOKA K, OKANO T: Thermo-responsive polymer nanoparticles with a core-shell micelle structure as sitespecific drug carriers.J. Control. Pfltase (1997)48:157-164.
69. CHUNG JE, YOKOYAMAM, SUZUKI K, AOYAGI T, SAKURAI Y, OKANO T: Reversibly thermo-responsive alkylterminatedpo!y(N-isopropylacriyIamide) core-shell micellar structures. Colloids Surf. B: Biointerf. (IW7) 9:37-48.
70. CHUNG JE, YOKOYAMAM, AOYAGI T, SAKURAI Y, OKANO T: Effect of molecular architecture of hydropbobically modified polylsopropylacrylamide on the formation of thremoresponsive core-shell micellar drug carriers.J. Conn: Release (1998)53:119-130.
71. KOHORIF, SAKAI K, AOYAGI T, YOKAYAMA M, SAKURAI Y, OKANO T: Preparation and characterization of thermally responsive block copolymer micelles comprising poly(Nisopropylacrylamide-b-Di-lactide).J. Contr. Release (1998) 55:87-98.
72. TAKEIYG,AOKIT,SANUIK,OGATA N, OKANO T, SAKURAIY: Temperatureresponsive bioconjugates. 2. Molecular design for temperature-modulated bioseparations. Bioconjug. Chem. (1993) 4:341-346.
73. BERMANJ, HOWARD RJ: Combinatorial drug discovery: concepts. In: Combinatorial Chemistry and Molecular Diversity in Drug Discovery. Gordon E, Kenvin J (Eds.), John Wiley & Sons, New York, USA (1998):447-452.
74. KATRITZKYAR.LOBANOV VS, KARELSON M: QSPR: the correlation and quantitative prediction of chemical and physical properties from structure. Chem. Soc. Rtv. (1995) 24:279-284.
75. BICERANO J: Prediction of polymer properties. Marcel Dekker, New York, USA (1993).
76. BROCCHINIS, JAMES K, TANGPASUTHADOL V, KOHNJ: Structure-property correlation in a combinatorial library of degradable biomaterials.J. Biomed. Mater. Res. (1998) 42:66-75-
77. BROCCHINI S, JAMES K, TANGPASUTHADOLV, KOHNJ: A combinatorial approach for polymer design. J.Am. Chem. Soc. (1997) 119:4553-4554.
78. REYNOLDS CH: Designing diverse and focused combinatorial libraries of synthetic polymers.J. Comb. Chem. (1999) 1:297306.
79. HUIBERS PDT, LOBANOV VS, KATRIZKYAR, SHAH DO, KARELSON M: Prediction of critical micelle concentration using a quantitative structure-property relationship approach. 1. Nonionic surfactants. Langmuir (1996) 12:1462-1470.
80. SUN H: COMPASS: An ab initia forcefield optimized for condensed-phase applications - overview with details on alkane and benzene compounds. J. Phys. Chem. (1998) 102:7338-7364.
81. FRAAIJEJG.VANVLIMMERENBA, MAURITS NM et at: The dynamic meanfield density functional method and its application to the mesoscopic dynamics of quenched block copolymer melts. J. Chem. Phys. (1997) 106:4260-4269.
82. ALTEVOGT P, EVERS OA, FRAAIJE JG, MAURITS NM, VAN VLIMMEREN BA: The MesoDyn project: software for mesoscale chemical engineering.J. MoL
83. Struct. Theochem. (1999) 463:139-143.
84. WUSE, HOPKINSWK,SHEUYE: TPGS as a drug Carrier and adsorption enhancer. In: Proceedings of the International Symposium on the Controlled Release of Bioactivt Materials. Controlled Release Society, Deerfield, USA (1996):23.
85. LI Y, KWONGS: Micelle-like structures of poly(ethyleneoxide)-block-poly(2hydroxyethyl aspartamide)-methotrexate conjugates. Colloids Surfaces B: Biointerfaces. (1999) 16:217-226.
86. REMPP P, MERILL EW: Polymer Synthesis. Hiithig & Wepf, Heidelberg, Germany (1986).
87. FOSTER S.ANTONIEITIM: Amphiphilic block copolymers in structurecontrolled nanomaterial hybrids. Adv. Mater. (1998) 10:195-217.
88. Amphiphilic Block Copolymers: Self-Assembly and Applications. Alexandridis P, Lineman B (Eds.), Elsevier, Amsterdam (1997).
89. VINOGRADOVSV.BRONICHTK, KABANOVA: Self-assembly of polyaminepoly(ethylene glycol) copolymers with phosphorothioate oligonucleotides. Bioconjug. Chem. (1998) 9:805-812.
90. KWON GS, KATAOKA K: Block copolymer micelles as long-circulating drug vehicles. Adv. DrugDcliv. Rev. (1995) 16:295-309.
91. BROMBERG L: Novel family of thermogelling materials via C-C bonding between poly(acrylic acid) and poly(ethyIeneoxide)-&-poIy(propyIene oxide)-£-poly(ethylene oxide).J. Phys. Chem. (1998) 102:1956-1963.
92. BROMBERG L, TEMCHENKO M: Selfassembly in aqueous solutions of poly(ethylene oxide)-poly(propylene oxide)poly(ethylene oxide)-£-poly(vinyl alcohol). Lmgma/r(1999) 15:8633-8639.
93. JEONGB.BEAYH.KIMSW: Biodegradable thermosensitivc micelles of PEG-PLGA-PEG triblock copolymers. Colloids and Surfaces B: Biointerfaces (1999) 16:185-193.
94. H1LLMYER MA, BATES FS: Synthesis and characterization of model polyalkanepoly(ethylene oxide) block copolymers. Macromolfcules(\W6) 29:6994-7002.
95. GORDON EM, GALLOP MA, PATEL DV: Strategy and tactics in combinatorial organic synthesis. Applications to drug discover)-. Ace. Chem. Res. (1996) 29:144154.
96. DOVE A: Drug screening - beyond the bottleneck. Nature Biottch. (1999) 17:859863.
97. ALAKHOVVY.MOSKALEVAEY, BATRAKOVA EV ttal.: Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer. Bioconjug. Chem. (1996) 7:209215.
98. BATRAKOVA EV, DORODNYCH TV, KLINSrai EY et ah. Anthracycline antibiotics non-covalcntly incorporated into the block copolymer micelles: in vivo evaluation of anti-cancer activity. Br. J. Cancer (1996) 74:1545-1553.
99. VENNEA,LIS,MANDEVILLERrt: Hypersensitizing effect of Pluronic L61 on cytotoxic activity, transport, and subcellular distribution of doxorubicin in multiple drug-resistant cells. Cancer Res. (1996) 56:3626-3632.
100. BATRAKOVA EV, LIS, MILLER DW, KABANOVAV: Pluronic P85 increases permeability of a broad spectrum of drugs in polarized BBMEC and Caco-2 cell monolayers. Pharm. Res. (1999) 16:13661372.
101. BATRAKOVA EV, HAN HY, ALAKHOV VYU, MILLER DW, KABANOV AV: Effects of pluronic block copolymers on drug absorption in Caco-2 cell monolayers. Pharm. Res. (1998) 15:850-855.
102. BATRAKOVA EV, HAN HY, MILLER DW, KABANOVAV: Effects of pluronic P85 unimers and micelles on drug permeability in polarized BBMEC and Caco-2 cells. Pharm. Res. (1998) 15:15251532.
103. MILLER DW, BATRAKOVA EV, KABANOVAV: Inhibition of multidrug resistance-associated protein (MRP) functional activity with pluronic block copolymers. Pharm. Res. (1999) 16:396401.
104. LEMIEUXP.GUERINN, PARADIS G et ai: A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther. (2000) 7:986-991.
105. GOLDSTEIN LJ, GOTTESMAN MM, PASTAN I: Expression of the MDR1 gene in human cancers. Cancer Treat. Res. (1991) 57:101-112.
106. GOLDSTEIN LJ, GOTTESMAN MM, PASTAN I: Multidrug resistance in human
107. cancer. Crit. Rev. OncoL HematoL (1992) 12:243-256.
108. LEPAGE P, GROSS P: Structural and functional aspects of P-glycoproteins and related transport proteins. Curr. Of in. Ntfhrol. Hypertens. (1993) 2:735-745.
109. SADEQUE AJ, WANDEL C, HE H, SHAH S, WOOD AJ: Increased drug delivery to the brain by P-glycoprotein inhibition, dm. Pbarmacol Thtr. (2000) 68:231-237.
110. SCHWARZ ULGRAMATTET, KRAPPWEIS J, OERTEL R, KIRCH W: P-glycoprotein inhibitor eryrhromycin increases oral bioavailability of talinolol in humans. Int. J, Clin. Pbarmacol Ther. (2000) 38:161-167.
111. LOTSCHJ.TEGEDERI.ANGSTMS, GEISSLINGER G: Antinociceptive effects of morphine-6-glucuronide in homozygous MDRla P-glycoprotein knockout and in wild type mice in the hotplate test. Life Set. (2000) 66:2393-2403.
112. HABGOODMD.BEGLEYDJ, ABBOTT NJ: Determinants of passive drug entry into the central nervous system. CillMoL Neurobiol (2000) 20:231-253.
113. KABANOVAV, BATRAKOVAEV, MELIK-NUBAROV NS a ai: A new class of drug carriers: micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain.J. Contr. Release (1992) 22:141-156.
114. BATRAKOVA EV, MILLER DW, LI S, ALAKHOVVYU, KABANOVAV, ELMQUIST WF: Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies. JPET (2001) 296 (In Press).
115. BANERJEE SK, JAGANNATH C, HUNTER RL, DASGUPTA A: Bioavailability of tobramycin after oral delivery in FVB mice using CRL-1605 copolymer, an inhibitor of P-glycoprotein. Life Set. (2000) 67(16):2011-2016.
116. CHANG T, BENET LZ, HEBERT MF: The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers. Clin. PharmacoL Ther. (1996) 59(3):297-303.
117. BUCKINGHAM LE, BALASUBRAMANIAN M, SAFA AR et al: Reversal of multi-drug resistance in vitro by fatty acid-PEG-fatty acid diesters. Int. J. Cz>-(1996)65(l):74-79.
118. JAGANNATH C, WELLS A, MSHVILDADZE M et ai: Significantly improved oral uptake of amikacin in FVB mice in the presence of CRL-1605 copolymer. Lift Sei. (1999) 64(19):17331738.
119. EVERSR.KOOLM, SMITH AJ, VAN DEEMTER L, DE HAAS M, BORST P: Inhibitory effect of the reversal agents V104, GF120918 and Pluronic L61 on MDR1 Pgp-,MRPl-andMRP2-mediated transport. Br.J. Cancer (2000) 83(3):366374
120. WOLFF JA, MALONERW, WILLIAMS P, CHONG W, ACSADIG, JAM A, FELGNER P: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465-1468.
121. FELGNER P: Direct gene transfer into mouse muscle in vivo. Science (1990) 247:1465-1468.
122. TOKUIM, TAKEI I, TASHIRO F et ai: Intramuscular injection of expression plasmid DNA is an effective means of longterm systemic delivery of interleukin-5. Biochem. Biophys. Res. Commun. (1997)
123. TRIPATHY SK, SVENSSON EC, BLACK HB etaL: Long-term expression of erythropoietin in the systemic circulation of mice after intramuscular injection of a plasmid DNA vector. Proc. NatL AcaJ. Set. USA (1996) 93:10876-10880.
124. LATHI KG, VALE PR, LOSORDODWrt aL: Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results. Antsth.Analg. (2001) 92(l):19-25.
125. LAHAMRJ,CHRONOSNA,PIKEM aL: Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischémie heart disease: results of a Phase I open-label dose escalation study.J. Am. ColL CardwL (2000) 36(7):2132-2139.
126. ROLLAND AP, MUMPER RJ: Plasmid delivery to musde: recent advances in polymer delivery systems. Adv. Drug Deliv. • A. (1998)30:151-117.
127. MUMPER RJ, DUGUID JG, ANWER K, BARRON MK, NOTA H, ROLLAND AP: PVP as novel interactive polymers for
128. controlled gene delivery to muscle. Pharm. Res. (1996) 13:701-709.
129. ZHOUS, MURPHY JE, DWARKIVJ: Adeno-associated virus-mediated deliver)-of erythropoietin leads to sustained elevation of hematocrit in nonhuman primates. Gene Ther. (1998) 5:665-670.
130. Handbook of Pharmaceutical Excipients. American Pharmaceutical Association, Washington, The Pharmaceutical Press, London (1994).